Source 1review2020Nature Reviews Drug Discovery
Toolkit/inorganic nanoparticles
inorganic nanoparticles
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
The supplied summary states that the review centers on engineering lipid-based, polymeric, and inorganic nanoparticles to overcome delivery barriers.
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Published Workflows
Objective: Engineer and evaluate resveratrol nanoformulations that improve delivery performance while reducing safety risk.
Why it works: The review frames nanoencapsulation and formulation optimization as a way to address the physicochemical instability, poor permeability, and rapid metabolism that limit resveratrol efficacy.
nanoencapsulationtargeted deliverycontrolled or improved drug releasenanodelivery system selectionnanoformulation optimizationin vivo testing
Stages
- 1.Nanoformulation design and carrier selection(library_design)
The abstract identifies multiple carrier classes as promising approaches to improve resveratrol delivery performance.
Selection: Choose among nanodelivery system classes for resveratrol nanoencapsulation.
- 2.Formulation optimization(functional_characterization)
The review describes strategies to improve key formulation properties of existing nanoformulations.
- 3.In vivo safety-oriented testing across disease settings(in_vivo_validation)
The abstract explicitly states that in vivo testing is needed to avoid potential safety issues.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A delivery strategy grouped with the mechanism branch because it determines how a system is instantiated and deployed in context.
Mechanisms
cargo encapsulationenhanced permeability and retention effectprotein corona-mediated modulation of biological identityTechniques
No technique tags yet.
Target processes
editingValidation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Source 2primary paper2026MED
Source 3review2023Drug Delivery
Ranked Claims
Nanoparticle-based delivery systems can improve the stability, circulation time, and tumor-targeting precision of encapsulated CRISPR components.
The NTLA-2001 trial demonstrated the first successful use of lipid nanoparticles for in vivo CRISPR delivery in humans.
Current nanoparticle-enhanced CRISPR delivery approaches remain limited by poor delivery to solid tumors, potential off-target effects, and inconsistent nanoparticle formulations.
Multiple nanodelivery system classes have shown great potential to improve the solubility, biocompatibility, and therapeutic efficacy of resveratrol.
Nanodelivery systems, such as liposomes, polymeric nanoparticles, lipid nanocarriers, micelles, nanocrystals, inorganic nanoparticles, nanoemulsions, protein-based nanoparticles, exosomes, macrophages, and red blood cells (RBCs) have shown great potential for improving the solubility, biocompatibility, and therapeutic efficacy of resveratrol.
Heterogeneity is presented as a central design problem for nanoparticle drug delivery in precision medicine.
The review scope explicitly includes lipid-based, polymeric, and inorganic nanoparticle systems as major precision-delivery platform classes.
Protein corona is treated as a relevant determinant of nanoparticle biological identity and delivery behavior in the review's design context.
The enhanced permeability and retention effect is presented as heterogeneous and therefore insufficient as a uniform assumption for precision nanomedicine design.
The review frames precision nanoparticle engineering as a strategy to overcome systemic, microenvironmental, and cellular barriers to drug delivery.
Approval Evidence
3 sources4 linked approval claimsfirst-pass slug inorganic-nanoparticles
By encapsulating CRISPR components within lipid, polymeric, or inorganic nanoparticles, researchers have improved their stability, circulation time, and tumor-targeting precision.
Source:
Nanodelivery systems, such as ... inorganic nanoparticles ... have shown great potential for improving the solubility, biocompatibility, and therapeutic efficacy of resveratrol.
Source:
The supplied summary states that the review centers on engineering lipid-based, polymeric, and inorganic nanoparticles to overcome delivery barriers.
Source:
capability statementsupports
Nanoparticle-based delivery systems can improve the stability, circulation time, and tumor-targeting precision of encapsulated CRISPR components.
Source:
limitation statementsupports
Current nanoparticle-enhanced CRISPR delivery approaches remain limited by poor delivery to solid tumors, potential off-target effects, and inconsistent nanoparticle formulations.
Source:
review summarysupports
Multiple nanodelivery system classes have shown great potential to improve the solubility, biocompatibility, and therapeutic efficacy of resveratrol.
Nanodelivery systems, such as liposomes, polymeric nanoparticles, lipid nanocarriers, micelles, nanocrystals, inorganic nanoparticles, nanoemulsions, protein-based nanoparticles, exosomes, macrophages, and red blood cells (RBCs) have shown great potential for improving the solubility, biocompatibility, and therapeutic efficacy of resveratrol.
Source:
material class scopesupports
The review scope explicitly includes lipid-based, polymeric, and inorganic nanoparticle systems as major precision-delivery platform classes.
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.
- 2.
- 3.